StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$48.22+0.22 (+0.46%)

Close on Nov 17, 2026Market cap $2.28BP/E 13.5Yield –

Prestige Consumer Healthcare ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Prestige Consumer Healthcare's ebitda for the twelve months ending Jun 30, 2026 was $322.53M, down 11.9% year over year. For fiscal 2026 it was $340.68M, down 7.2% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $373.10M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2026Mar 31, 2026$340.68M-7.2%
FY2025Mar 31, 2025$366.95M-1.6%
FY2024Mar 31, 2024$373.10M+3554.3%
FY2023Mar 31, 2023$10.21M-97.2%
FY2022Mar 31, 2022$362.01M+10.5%
FY2021Mar 31, 2021$327.57M+2.3%
FY2020Mar 31, 2020$320.15M+222.5%
FY2019Mar 31, 2019$99.28M-60.1%
FY2018Mar 31, 2018$248.90M+7.5%
FY2017Mar 31, 2017$231.44M-18.5%
FY2016Mar 31, 2016$283.99M+26.1%
FY2015Mar 31, 2015$225.30M+11.5%
FY2014Mar 31, 2014$202.10M-1.5%
FY2013Mar 31, 2013$205.12M+80.6%
FY2012Mar 31, 2012$113.56M+31.7%
FY2011Mar 31, 2011$86.25M-3.9%
FY2010Mar 31, 2010$89.78M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$61.27M-22.9%
Q4 FY2026CQ1 2026Mar 31, 2026$83.84M-12.4%
Q3 FY2026CQ4 2025Dec 31, 2025$90.08M-8.9%
Q2 FY2026CQ3 2025Sep 30, 2025$87.33M-5.3%
Q1 FY2026CQ2 2025Jun 30, 2025$79.42M-0.9%
Q4 FY2025CQ1 2025Mar 31, 2025$95.68M+6.3%
Q3 FY2025CQ4 2024Dec 31, 2024$98.83M+4.6%
Q2 FY2025CQ3 2024Sep 30, 2024$92.27M-3.8%
Q1 FY2025CQ2 2024Jun 30, 2024$80.17M-13.6%
Q4 FY2024CQ1 2024Mar 31, 2024$90.00M–
Q3 FY2024CQ4 2023Dec 31, 2023$94.48M-0.9%
Q2 FY2024CQ3 2023Sep 30, 2023$95.89M+3.5%
Q1 FY2024CQ2 2023Jun 30, 2023$92.74M-2.8%
Q4 FY2023CQ1 2023Mar 31, 2023-$273.13M-417.9%
Q3 FY2023CQ4 2022Dec 31, 2022$95.31M+5.2%
Q2 FY2023CQ3 2022Sep 30, 2022$92.63M+7.1%
Q1 FY2023CQ2 2022Jun 30, 2022$95.40M-3.6%
Q4 FY2022CQ1 2022Mar 31, 2022$85.91M+9.5%
Q3 FY2022CQ4 2021Dec 31, 2021$90.64M+11.8%
Q2 FY2022CQ3 2021Sep 30, 2021$86.52M+7.5%
Q1 FY2022CQ2 2021Jun 30, 2021$98.94M+13.0%
Q4 FY2021CQ1 2021Mar 31, 2021$78.47M-3.4%
Q3 FY2021CQ4 2020Dec 31, 2020$81.05M-3.3%
Q2 FY2021CQ3 2020Sep 30, 2020$80.45M+5.1%
Q1 FY2021CQ2 2020Jun 30, 2020$87.59M+11.5%
Q4 FY2020CQ1 2020Mar 31, 2020$81.25M–
Q3 FY2020CQ4 2019Dec 31, 2019$83.79M-1.9%
Q2 FY2020CQ3 2019Sep 30, 2019$76.57M-3.0%
Q1 FY2020CQ2 2019Jun 30, 2019$78.55M-2.9%
Q4 FY2019CQ1 2019Mar 31, 2019-$145.92M–
Q3 FY2019CQ4 2018Dec 31, 2018$85.43M-7.4%
Q2 FY2019CQ3 2018Sep 30, 2018$78.92M-6.3%
Q1 FY2019CQ2 2018Jun 30, 2018$80.86M-7.5%
Q4 FY2018CQ1 2018Mar 31, 2018-$15.05M-125.0%
Q3 FY2018CQ4 2017Dec 31, 2017$92.23M+22.7%
Q2 FY2018CQ3 2017Sep 30, 2017$84.26M+9.3%
Q1 FY2018CQ2 2017Jun 30, 2017$87.46M–
Q4 FY2017CQ1 2017Mar 31, 2017$60.15M–
Q3 FY2017CQ4 2016Dec 31, 2016$75.14M–
Q2 FY2017CQ3 2016Sep 30, 2016$77.07M–

More Prestige Consumer Healthcare figures

See a number that looks wrong?